Monoclonal antibody treatments are saving lives from COVID-19 and helps keep patients out of Triangle hospitals. Doctors are infusing newly diagnosed COVID-19 patients with antibodies that have been ...

On the same day North Carolina hospitals reported a record number of COVID-19 patients in intensive care units across the state, Gov. Roy Cooper signaled he will take action expanding access to a ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...

NEW YORK (WABC) -- Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the omicron variant of the coronavirus ...

If you’re older than 12 and test positive for COVID-19, you most likely qualify to receive monoclonal antibody treatment on Texas’ dime. For most, the largest barrier to getting the early-stage ...

JACKSONVILLE, Fla. -- Toma Dean had been in and out of the emergency room for the past two weeks, "extremely sick" with COVID-19, when she arrived at a Jacksonville, Florida, monoclonal antibody ...

A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high antibody levels in the airway—offering a faster and more effective way to fight COVID-19.

Aug 31 (Reuters) - GlaxoSmithKline (GSK.L), opens new tab and partner Vir Biotechnology (VIR.O), opens new tab have started testing their experimental antibody on early-stage COVID-19 patients, ...

Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...